Clinical Trial Update: Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib

View source ↗

Summary

A retrospective study evaluating sequential therapy in patients with metastatic renal cell carcinoma treated with VEGFR tyrosine kinase inhibitors, mTOR inhibit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• Bevacizumab (bevacizumab)
• Everolimus (everolimus)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Kidney Neoplasms | Status: UNKNOWN